Emergence of rifampicin-resistant staphylococci on the skin and nose of rifampicin-treated patients with an orthopaedic-device-related infection-Reference-Cited by-同舟云学术

Emergence of rifampicin-resistant staphylococci on the skin and nose of rifampicin-treated patients with an orthopaedic-device-related infection

Published:2024-07-24 Issue:4 Volume:9 Page:191-196
ISSN:2206-3552
Container-title:Journal of Bone and Joint Infection
language:en
Short-container-title:J. Bone Joint Infect.

Author:

Wallimann Alexandra,Achermann Yvonne^ORCID,Ferris Ciara,Morgenstern Mario^ORCID,Clauss Martin^ORCID,Stadelmann Vincent,Rüdiger Hannes Andreas,O'Mahony Liam^ORCID,Moriarty Thomas Fintan

Abstract

Abstract. Rifampicin is a key antibiotic in the treatment of staphylococcal biofilm infections. In this pilot study, we found that patients who received rifampicin for treatment of an orthopaedic-device-related infection (ODRI) were colonized with rifampicin-resistant staphylococci during treatment and this persisted for up to 2 months after cessation of treatment.

Funder

AO Foundation

Publisher

Copernicus GmbH

Link

https://jbji.copernicus.org/articles/9/191/2024/jbji-9-191-2024.pdf

Reference11 articles.

1. Achermann, Y., Eigenmann, K., Ledergerber, B., Derksen, L., Rafeiner, P., Clauss, M., Nüesch, R., Zellweger, C., Vogt, M., and Zimmerli, W.: Factors associated with rifampin resistance in staphylococcal periprosthetic joint Infections (PJI): A matched case–control study, Infection, 41, 431–437, https://doi.org/10.1007/s15010-012-0325-7, 2013.

2. Goldstein, B. P.: Resistance to Rifampicin: A Review, J. Antibiot., 67, 625–630, https://doi.org/10.1038/ja.2014.107, 2014.

3. Hellmark, B., Unemo, M., Nilsdotter-Augustinsson, Å., and Söderquist, B.: Antibiotic Susceptibility among Staphylococcus Epidermidis Isolated from Prosthetic Joint Infections with Special Focus on Rifampicin and Variability of the RpoB Gene, Clin. Microbiol. Infec., 15, 238–244, https://doi.org/10.1111/j.1469-0691.2008.02663.x, 2009.

4. Ju, O., Woolley, M., and Gordon, D.: Emergence and Spread of Rifampicin-Resistant, Methicillin-Resistant Staphylococcus Aureus during Vancomycin–Rifampicin Combination Therapy in an Intensive Care Unit, Eur. J. Clin. Microbiol. Infect. Dis., 25, 61–62, https://doi.org/10.1007/s10096-005-0063-1, 2006.

5. Lai, C. C., Che-Kim, T., Sheng-Hsiang, L., Chun-Hsing, L., Yu-Tsung, H., and Po-Ren, H.: Emergence of rifampicin resistance during rifampicin-containing treatment in elderly patients with persistent methicillin-resistant staphylococcus aureus bacteremia, J. Am. Geriatr. Soc., 58, 1001–1003, https://doi.org/10.1111/j.1532-5415.2010.02842.x, 2010.